Wall Street's Most Accurate Analysts Say Hold These 3 Real Estate Stocks With Over 4% Dividend Yields

Author: Avi Kapoor | March 19, 2024 08:13am

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our Analyst Stock Ratings page. Traders can sort through Benzinga's extensive database of analyst ratings, including by analyst accuracy .

Below are the ratings of the most accurate analysts for three high-yielding stocks in the real estate sector.

PotlatchDeltic Corporation (NASDAQ:PCH)

• Dividend Yield: 4.07%
• RBC Capital analyst Matthew McKellar reiterated a Sector Perform rating with a price target of $48 on Jan. 31, 2024. This analyst has an accuracy rate of 64%.
• Truist Securities analyst Michael Roxland maintained a Hold rating and cut the price target from $51 to $49 on Jan. 31, 2024. This analyst has an accuracy rate of 67%.
• Recent News: On Jan. 29, PotlatchDeltic posted better-than-expected quarterly sales.

Healthcare Realty Trust Incorporated (NYSE:HR)

• Dividend Yield: 9.45%
• Wedbush analyst Richard Anderson downgraded the stock from Outperform to Neutral and cut the price target from $19 to $15 on Feb. 20, 2024. This analyst has an accuracy rate of 62%.
• Citigroup analyst Michael Griffin maintained a Neutral rating and slashed the price target from $19 to $17 on Aug. 22, 2023. This analyst has an accuracy rate of 74%.
• Recent News: On Feb. 16, Healthcare Realty Trust posted a decline in sales for the fourth quarter.

National Health Investors, Inc. (NYSE:NHI)

• Dividend Yield: 5.94%
• Wells Fargo analyst Todd Stender maintained an Equal-Weight rating and raised the price target from $54 to $55 on Nov. 27, 2023. This analyst has an accuracy rate of 68%.
• Jefferies analyst Joe Dickstein initiated coverage on the stock with a Hold rating and a price target of $52 on Sept. 20, 2023. This analyst has an accuracy rate of 64%.
• Recent News: On Feb. 20, National Health Investors posted better-than-expected quarterly results.

 

Read More: Core & Main, Caleres And 3 Stocks To Watch Heading Into Tuesday

 

Posted In: HR NHI PCH